Breakthrough Liver Cancer Treatment Found


	Breakthrough Liver Cancer Treatment Found

RecordSage

6-4-2007 2:15 PM

259 views

tags:

liver, cancer, treatment, breakthrough, health, nexavar, bayer

1 Comment |

Add a Comment

5-13-2008 1:15 AM

juliedawn

This sounds promising. I have a friend who has liver cancer. Thank you.

Login to Comment. Not a member yet? Sign up

View the Top Clips from June 4, 2007

Embed This Clip In Your Site...

<div style="margin: 12px 0px; font-family: arial; color: #333333; background: #ffffff; border: solid 4px #e5e5e5; width: 100%; clear: left;"><div class="CM_CTB_Content_Wrap" style="margin: 0px; padding: 0px;background-color: #ffffff;"><div style="border-bottom: solid 1px #dcdcdc; white-space: nowrap; margin-bottom: 8px; background-color: #eeeeee ;background-image: url(http://clipmarks.com/images/source-bg.gif); background-repeat: repeat-x; height: 24px; line-height: 24px; vertical-align: middle; padding-bottom: 4px; color: #666666; font-size: 10px;" ><a href="http://clipmarks.com/clip-to-blog/" title="see clips that are hot right now"><img src="http://content.clipmarks.com/blog_embed/b4ffe0fd-3531-4f04-b380-4c4c2e3a9012/78875C23-5AED-4C64-AB55-86861B49B24C/" alt="" width="19" height="19" border="0" style="vertical-align: middle; margin: 0px 4px; display: inline; border: none; float:none;" /></a>clipped from <a title="http://www.forbes.com/forbeslife/health/feeds/hscout/2007/06/04/hscout605233.html" href="http://www.forbes.com/forbeslife/health/feeds/hscout/2007/06/04/hscout605233.html" style="font-size: 11px;">www.forbes.com</a></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.forbes.com/forbeslife/health/feeds/hscout/2007/06/04/hscout605233.html"><P>Nexavar, made by Bayer, gave patients with advanced liver cancer
44 percent more time to live, compared to patients who did not
receive the drug, according to results presented Monday at the
annual meeting of the American Society of Clinical Oncology, in
Chicago.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.forbes.com/forbeslife/health/feeds/hscout/2007/06/04/hscout605233.html"><P>Results of a major clinical trial with Nexavar (sorafenib) were,
in fact, so successful that the trial was halted early, the
researchers announced.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.forbes.com/forbeslife/health/feeds/hscout/2007/06/04/hscout605233.html"><P>"This is the first systemic therapy to prolong survival in
[liver cancer] patients," said Dr. Joseph Llovet, lead author
of the study and director of research in liver cancer at Mount
Sinai School of Medicine in New York City. "This is a new
reference standard for systemic therapy of [liver cancer] patients
after 30 years of research and more than 100 randomized controlled
trials performed."</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://www.forbes.com/forbeslife/health/feeds/hscout/2007/06/04/hscout605233.html"><P>Dr. Len Lichtenfeld, deputy chief medical officer of the
American Cancer Society, added, "This is going to change the
standard of practice."</P></blockquote></div><div style="margin: 0px 6px 6px 4px;"><table style="font-size: 11px;border-spacing: 0px;padding: 0px;" cellpadding="0" cellspacing="0" width="100%"><tr><td style="background:transparent;border-width:0px;padding:0px;">&nbsp;</td><td align="right" style="background:transparent;border-width:0px;padding:0px;width:107px" width="107"><a href="http://clipmarks.com/share/78875C23-5AED-4C64-AB55-86861B49B24C/blog/" title="blog or email this clip"><img src="http://content8.clipmarks.com/images/c2b-foot.png" border="0" alt="blog it" width="107" height="17" style="border-width:0px;padding:0px;margin:0px;" /></a></td></tr></table></div></div>